Literature DB >> 18210068

[Female sexual dysfunction].

J B Korda1.   

Abstract

Female sexual dysfunction (FSD) is a very common disorder in Germany with a prevalence of approximately 38%. FSD includes persistent or recurrent disorders of sexual desire, disorders of subjective or genital arousal and pain during intercourse. An overview of the epidemiology, the current definitions of the single domains of FSD, the pathophysiology and recommendations on the treatment of FSD is given.

Entities:  

Mesh：

Year:  2008        PMID： 18210068     DOI： 10.1007/s00120-007-1618-9

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  37 in total

1.  Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction.

Authors:  A Guay; J Jacobson; R Munarriz; A Traish; L Talakoub; F Quirk; I Goldstein; R Spark
Journal:  Int J Impot Res       Date:  2004-04       Impact factor: 2.896

2.  Sexual function and satisfaction in adults based on the definition of child sexual abuse.

Authors:  Alessandra Rellini; Cindy Meston
Journal:  J Sex Med       Date:  2007-09       Impact factor: 3.802

3.  Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial.

Authors:  Irwin Goldstein; William A Fisher; Michael Sand; Raymond C Rosen; Martin Mollen; Gerald Brock; Gary Karlin; Peter Pommerville; Keith Bangerter; Tiemo-Joerg Bandel; Leonard R Derogatis
Journal:  J Sex Med       Date:  2005-11       Impact factor: 3.802

Review 4.  Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition.

Authors:  Alessandra Graziottin; Sandra R Leiblum
Journal:  J Sex Med       Date:  2005-09       Impact factor: 3.802

5.  Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS).

Authors:  Sandra R Leiblum; Patricia E Koochaki; Cynthia A Rodenberg; Ian P Barton; Raymond C Rosen
Journal:  Menopause       Date:  2006 Jan-Feb       Impact factor: 2.953

6.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

7.  Vaginal spasm, pain, and behavior: an empirical investigation of the diagnosis of vaginismus.

Authors:  Elke D Reissing; Yitzchak M Binik; Samir Khalifé; Deborah Cohen; Rhonda Amsel
Journal:  Arch Sex Behav       Date:  2004-02

8.  Sexual dysfunction in stroke patients.

Authors:  J T Korpelainen; M L Kauhanen; H Kemola; U Malinen; V V Myllylä
Journal:  Acta Neurol Scand       Date:  1998-12       Impact factor: 3.209

9.  The impact of body awareness on sexual arousal in women with sexual dysfunction.

Authors:  Brooke N Seal; Cindy M Meston
Journal:  J Sex Med       Date:  2007-07       Impact factor: 3.802

10.  Women's sexual functioning, lifestyle, mid-age, and menopause in 12 European countries.

Authors:  Lorraine Dennerstein; Philippe Lehert
Journal:  Menopause       Date:  2004 Nov-Dec       Impact factor: 2.953
View more
  2 in total

1.  Evaluation of sexual function in sexually active women 1 year after transvaginal NOTES: a prospective cohort study of 106 patients.

Authors:  Georg R Linke; Stephanie Luz; Joanna Janczak; Andreas Zerz; Bruno M Schmied; Ikbale Siercks; René Warschkow; Ulrich Beutner; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2012-08-26       Impact factor: 3.445

2.  Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem.

Authors:  Giti Ozgoli; Zohre Sheikhan; Mahrokh Dolatian; Masoumeh Simbar; Maryam Bakhtyari; Malihe Nasiri
Journal:  J Reprod Infertil       Date:  2015 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.